Barbara Klencke - Insider Trading & Ownership

Entity
Individual
Location
C/O Sierra Oncology, Inc., 1820 Gateway Drive, Suite 110, San Mateo, CA
Summary
The estimated net worth of Barbara Klencke is at least $785K dollars as of September 24, 2024. Barbara Klencke is the Director of TScan Therapeutics, Inc. and owns shares of TScan Therapeutics, Inc. (TCRX) stock worth about $644K. Barbara Klencke is the Director of Xencor Inc and owns shares of Xencor Inc (XNCR) stock worth about $141K.
All Insider Reports
All Insider Reports

Ownership of Barbara Klencke

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TCRX TScan Therapeutics, Inc. Director $644K +$108K +20.2% Sep 23, 2024
XNCR Xencor Inc Director $141K Jun 13, 2024
EFTR, EFTRW eFFECTOR Therapeutics, Inc. Director Jun 13, 2024
SRRA Sierra Oncology, Inc. Chief Medical Officer Jul 1, 2022

Insider Transactions Reported by Barbara Klencke:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.